| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/09/2006 | CN1814017A Damp-repellent pain-relieving medicinal liquor of Herba siphonostegiae |
| 08/09/2006 | CN1814016A Collateral-flow-activating external-use medicine of Fodium Desmoris for treating injuries from falls |
| 08/09/2006 | CN1814010A Japanese supplejack collateral-flow-activating pain-relieving medicine |
| 08/09/2006 | CN1814002A Chinese medicine for treating femoral head necrosis |
| 08/09/2006 | CN1813992A Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls |
| 08/09/2006 | CN1813990A Cortex Berheridis Radicis external-use medicine |
| 08/09/2006 | CN1813986A Damp-repellent pain-relieving medicinal liquor of cortex Arallae Echinocaulis Rodicis |
| 08/09/2006 | CN1813980A Psychotria serpens total sterol and its medicinal composition and use |
| 08/09/2006 | CN1813978A Wind-repellent collateral-flow-activating pain-velieving medicine of caulis Tinosporae |
| 08/09/2006 | CN1813977A Collateral-flow-activating pain-relieving medicine of more than one lterba Achilleae |
| 08/09/2006 | CN1813963A External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows |
| 08/09/2006 | CN1813952A Medicine of yellow cinnamon root for activating collaterals |
| 08/09/2006 | CN1813948A Stahlianthus involucratus antalgic plaster for treating injury and activating collaterals |
| 08/09/2006 | CN1813946A Medicinal liquor of ardisia brevicaulis diels for dispelling wetness-eviland stopping pain |
| 08/09/2006 | CN1813945A External-use drug of croton seed tree root for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813942A External-use drug of helwingia himalaicahook for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813938A Medicine for treating bong arthritis and its preparing method |
| 08/09/2006 | CN1813930A Chinese medicine of securidaca inappendiculata hassk for activating collaterals and stopping pain |
| 08/09/2006 | CN1813928A External-use drug of canavalia gladiata for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813922A Medicinal liquor of Hongheierwan for dispelling wetness-evil and stopping pain |
| 08/09/2006 | CN1813907A External-use medicine of cordateleaf ainsliaea root for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813903A Barban drug for activating collaterals and stopping pain |
| 08/09/2006 | CN1813898A External-use medicine of hayberry bark for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813876A Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease |
| 08/09/2006 | CN1813871A Fuming-washing Chinese medicine for treating bone joint disease |
| 08/09/2006 | CN1813865A Medicine of lancileaf loosestrife root or herb for activing collaterals and stopping pain |
| 08/09/2006 | CN1813864A External-use medicine of thickleaf croton root for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813861A Five-ingredient medicinal-bathing particle |
| 08/09/2006 | CN1813856A Sunflower formulation |
| 08/09/2006 | CN1813854A External-use medicine of herb of seguin cobelia for traumatic injury and activating collaterals |
| 08/09/2006 | CN1813851A External-use powder for treating swelling anducler and actue-chronic osteomyelitis |
| 08/09/2006 | CN1813848A Medicinal composition for treating osteo porosis and its formulation |
| 08/09/2006 | CN1813847A Safflower lyophilized powder for injection and its preparing method |
| 08/09/2006 | CN1813831A Glabrous sarcandra herb lyophilized powder for injection, its high-dose injection and preparing method |
| 08/09/2006 | CN1813813A Method for preparing calcium phosphate containing chinese medicine |
| 08/09/2006 | CN1813792A Hyaluronic acid external-use health-care medicine for treating arthritis |
| 08/09/2006 | CN1813712A Method for preparing soybean isoflavone tablet |
| 08/09/2006 | CN1813672A Tourmaline multi functional beauty cream and its preapring method |
| 08/09/2006 | CN1813669A Wrinkle-removing eye paster and method for preparing its product |
| 08/09/2006 | CN1813668A Whitening wrinkle-removing face paster and method for preparing its product |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268386C Fracture setting Chinese medicine and its preparing process |
| 08/09/2006 | CN1268375C Chinese medicinal composition for treating bone fracture and soft tissue contusion |
| 08/09/2006 | CN1268372C Waist recovery plaster |
| 08/09/2006 | CN1268359C Medicine for treating osteomyelitis and its preparing method |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087248 Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component |
| 08/03/2006 | WO2006081251A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/03/2006 | WO2006081170A1 Nutritional supplement containing honey |
| 08/03/2006 | WO2006080884A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor |
| 08/03/2006 | WO2006080780A1 Pharmaceutical compositions containing bisphosphonate for improving oral absorption |
| 08/03/2006 | WO2006080533A1 3-amino-1,2,4-triazole derivative |
| 08/03/2006 | WO2006080323A1 Six-membered heterocyclic compound and the use thereof |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006079243A1 The use of flavonol and flavonol glycosides for stimulating growth of renal tubular epithelial cells to secrete the kidney secreting bone growth factor |
| 08/03/2006 | WO2006050734A3 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 08/03/2006 | WO2006046934A3 Osteoclastogenesis inhibitors and uses thereof |
| 08/03/2006 | WO2006046100B1 Pharmaceutical composition of alendronic acid |
| 08/03/2006 | WO2006000339A3 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173069 Therapeutic agent for hyperpotassemia and bone disease |
| 08/03/2006 | US20060173047 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 08/03/2006 | US20060173045 Preventative or remedy for grinding |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173033 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173009 Agent inducing increase in bone mass |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172947 Physiologically active peptides and drugs containing the same |
| 08/03/2006 | US20060172391 BMP-11 compositions |
| 08/03/2006 | US20060172019 Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171939 Remedy for degenerative intervertebral discs |
| 08/03/2006 | US20060171928 Monocyte-origin multipotent cell momc |
| 08/03/2006 | CA2595711A1 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685152A2 Il-18 binding proteins |